Financial reports
Current reports
6-K
About Today’s News Reports Regarding Personnel Downsizing
22 Sep 06
6-K
The Termination of the Contract concerning OTC Medicine
21 Sep 06
6-K
Current report (foreign)
11 Sep 06
6-K
DAIICHI SANKYO to Invest in the Healthcare Venture Fund
11 Sep 06
6-K
Current report (foreign)
31 Aug 06
6-K
Daiichi Wins FLOXIN® Otic Patent Challenge by Generic Manufacturer Apotex
3 Aug 06
6-K
Sales of Antihypertensive Agent Olmetec® Begin in China
3 Aug 06
6-K
Sankyo Commences Patent Litigation Against Benicar® Anda
2 Aug 06
6-K
Daiichi Pharmaceutical to Develop and Market Anti-EGFr Drug
1 Aug 06
6-K
Current report (foreign)
31 Jul 06
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
12 Nov 14
SC TO-T/A
Third party tender offer statement (amended)
28 Oct 14
SC TO-T/A
Third party tender offer statement (amended)
15 Oct 14
SC TO-T
Third party tender offer statement
10 Oct 14
SC TO-C
Information about tender offer
30 Sep 14
SC TO-C
Information about tender offer
29 Sep 14
SC TO-C
Information about tender offer
29 Sep 14
F-6
Registration for ADRs (foreign)
7 Nov 11
F-6EF
Automatic registration for ADRs (foreign)
30 Aug 11
F-6EF
Automatic registration for ADRs (foreign)
18 Feb 11
Proxies
No filings